Filings
Finds words inside filing documents. Searching Organon & Co.'s filings · 37 documents indexed.
15 documents · 46 matches
-
OGN Organon & Co. 10-K 2026-02-24
Item 1A. Risk Factors
tariffs on imports into the U.S., including an agreement with the EU that would limit U.S. tariffs to 15% on certain18 matches in this document -
OGN Organon & Co. 10-Q 2025-11-10
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs have not, to date, had a material impact on our business, future tariff actions could potentially have a significant5 matches in this document -
OGN Organon & Co. 10-Q/A 2025-11-10
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs have not, to date, had a material impact on our business, future tariff actions could potentially have a significant4 matches in this document -
OGN Organon & Co. 10-Q/A 2025-11-10
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs have not, to date, had a material impact on our business, future tariff actions could potentially have a significant2 matches in this document -
OGN Organon & Co. 10-Q 2025-08-06
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs have not, to date, had a material impact on our business, future tariff actions could potentially have a significant4 matches in this document -
OGN Organon & Co. 10-Q 2026-10-30
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs (including pharmaceutical sector tariffs), trade sanctions or similar restrictions by the United States or other governments; changes in U.S. and foreign2 matches in this document -
OGN Organon & Co. 10-Q 2026-07-31
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs (including pharmaceutical sector tariffs), trade sanctions or similar restrictions by the United States or other governments; changes in U.S. and foreign2 matches in this document -
OGN Organon & Co. 10-Q 2026-05-04
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
tariffs (including pharmaceutical sector tariffs), trade sanctions or similar restrictions by the United States or other governments; changes in U.S. and foreign2 matches in this document -
OGN Organon & Co. 8-K 2025-11-10
tariffs (including any potential pharmaceutical sector tariffs), trade sanctions or similar restrictions by the United States or other governments; changes1 match in this document -
OGN Organon & Co. 8-K 2025-11-10
tariffs (including any potential pharmaceutical sector tariffs), trade sanctions or similar restrictions by the Un ite d States or other1 match in this document -
OGN Organon & Co. 8-K 2025-08-05
tariffs (including any potential pharmaceutical sector tariffs), trade sanctions or similar restrictions by the United States or other governments; changes1 match in this document -
OGN Organon & Co. 8-K 2025-08-05
tariffs (including any potential pharmaceutical sector tariffs), trade sanctions or similar restrictions by the United States or other governments; changes1 match in this document -
OGN Organon & Co. 8-K 2025-05-27
tariffs (including any potential pharmaceutical sector tariffs), trade sanctions or similar restrictions by the United States or other governments; changes1 match in this document -
OGN Organon & Co. 8-K 2026-02-12
tariffs and other trade restrictions or domestic sourcing requirements; changes in tax laws including changes related to the taxation of foreign1 match in this document -
OGN Organon & Co. 8-K 2026-02-12
tariffs and other trade restrictions or domestic sourcing re quirements; changes in tax laws including changes related to the taxation1 match in this document
Page 1 of 1 · 15 documents